Outlook Therapeutics Names New CFO Ahead of LYTENAVA Launch

Company: Outlook Therapeutics · Event Type: CFO Transition · Incoming CFO: Kevin Lundquist · Outgoing CFO: Lawrence A. Kenyon · Date: August 27, 2026 Summary Outlook Therapeutics appointed Kevin Lundquist chief financial officer, treasurer, principal financial officer and principal accounting officer effective September 1. Lawrence…